Phia Group

rss

Phia Group Media


EEOC Vacates ADA and GINA Wellness Incentive Rules

On December 21, 2018
The Phia Group explains how the new EEOC's final rules on ADA and GINA will affect you. With a lack of rules, employers may have compliances risks.

Stop-Loss: The Forgotten Player in the Reference Based Pricing Game

On December 20, 2018
Learn why you need to put stop-loss high up on the laundry list of considerations when choosing to adopt referenced-based-pricing.

A Texas Judge Strikes Down Obamacare – Our Take

On December 17, 2018
The Phia Groups shares their expert opinion on Texas striking down on Obamacare. Learn more about how it could affect your future healthcare coverage.

The Phia Group Announces the Formation of Legal Compliance & Regulatory Affairs Team

On December 17, 2018
The Phia Group recently announced the formation of their Legal Compliance & Regulatory Affairs Team. Learn all the details today!

What to Expect in 2019 – Part 2

On December 12, 2018
To build on last month’s webinar (Part 1), join The Phia Group’s legal team for an hour on December 12, 2018, as they present the second part of this two-part series on What to Expect in 2019. Touching on topics such as appeals, stop-loss trends, reference-based pricing, and much more, this webinar will highlight current industry happenings and our predictions to help you look forward to the coming year. Just like last month: miss this one, and you’ll be left behind.

Take Two Premiums and Call Me in the Morning...

On December 6, 2018
Too many people are confusing the term ‘health care’ with ‘health insurance.' Learn more about how we break down the difference at Phia Group.

Responding to a IRS Letter 226J: Considerations and Common Mistakes

On December 5, 2018
If you are an applicable large employer, IRS could possibly be sending a Letter 226J notice your way. Will you be ready to respond accurately within 30 days?

Objectives for the CVS Health and Aetna Merger

On December 3, 2018
The CVS Health and Aetna merger was granted preliminary approval from the DOJ in October. Will it benefit them or the patients more? Click to learn more!